Sonnet BioTherapeutics Holdings, Inc.
SONNDelisted Dec 2, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001106838
Sonnet BioTherapeutics Holdings, Inc. was delisted on Dec 2, 2025; its insiders filed their last Form 4 on Dec 4, 2025; 27 institutions reported holding it in 13F filings for Q3 2025, worth $3.53M in total; no superinvestor held it.
Q3 2024 vs. Q2 2024
How the institutions holding Sonnet BioTherapeutics Holdings, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 11 | 1 | 3 | −7 |
| Shares | 586.2K | 520 | 443 | −585.3K (−99.9%) |
| Value | $550.0K | $488 | $2.97K | −$546.5K (−99.5%) |
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (1)
Institutions that held Sonnet BioTherapeutics Holdings, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock, Inc. | 65 | $435 | 0.00% |
Sold out (8)
Institutions that held Sonnet BioTherapeutics Holdings, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Armistice Capital, LLC | 272,000 | $255.0K |
| Sabby Management, LLC | 238,395 | $223.5K |
| Virtu Financial LLC | 32,687 | $31.0K |
| Geode Capital Management, LLC | 16,704 | $15.7K |
| Vanguard Group Inc | 14,726 | $13.8K |
| UBS Group AG | 3,997 | $3.75K |
| Bank of America Corp | 28 | $27 |
| Morgan Stanley | 4 | $4 |
Not filed for Q3 2024 yet (1)
Institutions that held Sonnet BioTherapeutics Holdings, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 520 | $488 |